Moreover, macrophage engulfment of mast cell granules may suppress excess activation [38], consistent with our findings that targeting CASP1/LYZ could ameliorate aberrant immunity and arrest DKD tubulointerstitial injury. This evidence concerns the gene CASP1 and diabetic kidney disease.